Zentiva Unveils Generic Drug Export Hub

BMI View: While many innovative pharmaceutical firms have identified pricing policies and weaknesses in Turkey's IP framework as key challenges that will continue to deter further capital investment in this market, Sanofi's generic drug arm Zentiva has not been discouraged to utilise this low-cost European market as a global export hub for its generic drug produce.

To read the full article, please choose one of the following options: